Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 4 (2007), Issue 7 (July)

1. Body weight changes with beta-blocker use: results from GEMINI.
   Am J Med, 120(7): 610-5. [Abstract] [Full-text]
2. Sliding scale insulin use: myth or insanity?
   Am J Med, 120(7): 563-7. [Abstract] [Full-text]
3. Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes.
   Am J Ophthalmol, 144(1): 124-6. [Abstract] [Full-text]
4. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure.
   J Am Coll Cardiol, 50(1): 32-6. [Abstract] [Full-text]
5. PSMD9 gene variants within NIDDM2 may rarely contribute to type 2 diabetes.
   J Cell Physiol, 212(3): 568-71. [Abstract] [Full-text]
6. Diabetes mellitus and risk of breast cancer: a meta-analysis.
   Int J Cancer, 121(4): 856-62. [Abstract] [Full-text]
7. Metallothionein rescues hypoxia-inducible factor-1 transcriptional activity in cardiomyocytes under diabetic conditions.
   Biochem Biophys Res Commun, 360(1): 286-9. [Abstract] [Full-text]
8. Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.
   N Engl J Med, 357(1): 28-38. [Abstract] [Full-text]
9. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis.
   Tissue Antigens, 70(2): 110-27. [Abstract] [Full-text]
10. Administrative data algorithms can describe ambulatory physician utilization.
    Health Serv Res, 42(4): 1783-96. [Abstract] [Full-text]
11. Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability.
    Circ Res, 101(1): 106-10. [Abstract] [Full-text]
12. The late dividing population of gamma-retroviral vector transduced human mobilized peripheral blood progenitor cells contributes most to gene-marked cell engraftment in nonobese diabetic/severe combined immunodeficient mice.
    Stem Cells, 25(7): 1807-13. [Abstract] [Full-text]
13. Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study.
    Ophthalmology, 114(7): 1332-40. [Abstract] [Full-text]
14. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.
    Am J Surg, 194(2): 221-4. [Abstract] [Full-text]
15. Pregabalin: an antiepileptic agent useful for neuropathic pain.
    Am J Health Syst Pharm, 64(14): 1475-82. [Abstract] [Full-text]
16. Diabetes-induced bradycardia is an intrinsic metabolic defect reversed by carnitine.
    Metabolism, 56(8): 1118-23. [Abstract] [Full-text]
17. Metabolic syndrome, insulin resistance, and atherosclerosis in Japanese type 2 diabetic patients.
    Metabolism, 56(8): 1099-103. [Abstract] [Full-text]
18. Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus.
    Metabolism, 56(8): 1087-92. [Abstract] [Full-text]
19. The effects of pioglitazone on cerebrovascular resistance in patients with type 2 diabetes mellitus.
    Metabolism, 56(8): 1081-6. [Abstract] [Full-text]
20. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat--role of food intake and corticosterone.
    Metabolism, 56(8): 1065-75. [Abstract] [Full-text]
21. Effects of cardiopulmonary bypass on neurocognitive performance and cytokine release in old and diabetic rats.
    Br J Anaesth, 99(2): 177-83. [Abstract] [Full-text]
22. Comparison of adolescents with and without diabetes on indices of psychosocial functioning for three years.
    J Pediatr Psychol, 32(7): 794-806. [Abstract] [Full-text]
23. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.
    JAMA, 298(2): 194-206. [Abstract] [Full-text]
24. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis.
    JAMA, 298(2): 187-93. [Abstract] [Full-text]
25. Maternal trait anxiety and diabetes control in adolescents with type 1 diabetes.
    J Pediatr Psychol, 32(7): 733-44. [Abstract] [Full-text]
26. Relationship of literacy and heart failure in adults with diabetes.
    BMC Health Serv Res, 7: 98. [Abstract] [Full-text]
27. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review.
    BMJ, 335(7610): 87. [Abstract] [Full-text]
28. The epididymal fat pad as a transplant site for minimal islet mass.
    Transplantation, 84(1): 122-5. [Abstract] [Full-text]
29. Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial.
    Transplantation, 84(1): 89-96. [Abstract] [Full-text]
30. The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim report.
    Transplantation, 84(1): 17-22. [Abstract] [Full-text]
31. A comparison of risk factors for calcified atherosclerotic plaque in the coronary, carotid, and abdominal aortic arteries: the diabetes heart study.
    Am J Epidemiol, 166(3): 340-7. [Abstract] [Full-text]
32. Side population hematopoietic stem cells promote wound healing in diabetic mice.
    Plast Reconstr Surg, 120(2): 407-11; discussion 412-3. [Abstract] [Full-text]
33. Pharmacoeconomic analysis of angiotensin-converting enzyme inhibitors in type 2 diabetes: a Markov model.
    Ann Pharmacother, 41(7): 1101-10. [Abstract] [Full-text]
34. Attenuation of plasma dyslipidemia and oxidative damage by dietary caloric restriction in streptozotocin-induced diabetic rats.
    Chem Biol Interact, 169(1): 32-41. [Abstract] [Full-text]
35. Beneficial effect of succinic acid monoethyl ester on erythrocyte membrane bound enzymes and antioxidant status in streptozotocin-nicotinamide induced type 2 diabetes.
    Chem Biol Interact, 169(1): 15-24. [Abstract] [Full-text]
36. Increased hospital morbidity among trauma patients with diabetes mellitus compared with age- and injury severity score-matched control subjects.
    Arch Surg, 142(7): 613-8. [Abstract] [Full-text]
37. Microvascular tissue plasminogen activator is reduced in diabetic neuropathy.
    Neurology, 69(3): 268-74. [Abstract] [Full-text]
38. Weight-related increases in hypertension, hypercholesterolemia, and diabetes risk in normal weight male and female runners.
    Arterioscler Thromb Vasc Biol, 27(8): 1811-9. [Abstract] [Full-text]
39. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
    Heart, 93(8): 968-73. [Abstract] [Full-text]
40. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis.
    Clin Infect Dis, 45(4): 428-35. [Abstract] [Full-text]
41. Hyperglycemia increases the levels of vascular cellular adhesion molecule-1 and monocyte-chemoattractant-protein-1 in the diabetic endothelial cell.
    Biochem Biophys Res Commun, 360(3): 560-5. [Abstract] [Full-text]
42. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial.
    BMJ, 335(7611): 132. [Abstract] [Full-text]
43. Soluble RAGE in type 2 diabetes: association with oxidative stress.
    Free Radic Biol Med, 43(4): 511-8. [Abstract] [Full-text]
44. Lithium-induced nephrogenic diabetes insipidus after coronary artery bypass.
    Ann Thorac Surg, 84(2): 656-7. [Abstract] [Full-text]
45. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Am Heart J, 154(2): 277.e1-8. [Abstract] [Full-text]
46. Postprandial hyperinsulinaemic hypoglycaemia and type 1 diabetes mellitus.
    Arch Dis Child, 92(8): 714-5. [Abstract] [Full-text]
47. Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus.
    Am J Health Syst Pharm, 64(15): 1603-10. [Abstract] [Full-text]
48. Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy.
    Biochem Biophys Res Commun, 360(4): 772-7. [Abstract] [Full-text]
49. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial.
    Nat Clin Pract Nephrol, 3(8): 428-38. [Abstract] [Full-text]
50. Soluble insulin receptor ectodomain is elevated in the plasma of patients with diabetes.
    Diabetes, 56(8): 2028-35. [Abstract] [Full-text]
51. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy.
    Diabetes, 56(8): 2155-60. [Abstract] [Full-text]
52. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes.
    Diabetes, 56(8): 2142-7. [Abstract] [Full-text]
53. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
    Diabetes, 56(8): 2036-45. [Abstract] [Full-text]
54. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
    Diabetes, 56(8): 2178-82. [Abstract] [Full-text]
55. Surrogate markers of small fiber damage in human diabetic neuropathy.
    Diabetes, 56(8): 2148-54. [Abstract] [Full-text]
56. Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?
    Diabetes, 56(8): 1951-9. [Abstract] [Full-text]
57. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects.
    Diabetes, 56(8): 2174-7. [Abstract] [Full-text]
58. Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study.
    Diabetes, 56(8): 2161-8. [Abstract] [Full-text]
59. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Diabetes, 56(8): 2116-23. [Abstract] [Full-text]
60. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.
    Diabetes, 56(8): 2016-27. [Abstract] [Full-text]
61. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
    Diabetes, 56(8): 2169-73. [Abstract] [Full-text]
62. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Diabetes, 56(8): 2110-5. [Abstract] [Full-text]
63. Progression to type 2 diabetes characterized by moderate then rapid glucose increases.
    Diabetes, 56(8): 2054-61. [Abstract] [Full-text]
64. Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.
    Diabetes, 56(8): 2103-9. [Abstract] [Full-text]
65. Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes.
    Diabetes, 56(8): 2046-53. [Abstract] [Full-text]
66. Invited commentary: untangling the web of diabetes causality in African Americans.
    Am J Epidemiol, 166(4): 388-90; discussion 391-2. [Abstract] [Full-text]
67. The effect of adverse housing and neighborhood conditions on the development of diabetes mellitus among middle-aged African Americans.
    Am J Epidemiol, 166(4): 379-87. [Abstract] [Full-text]
68. Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes.
    Am J Epidemiol, 166(4): 393-402. [Abstract] [Full-text]
69. Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms.
    Muscle Nerve, 36(2): 144-66. [Abstract] [Full-text]
70. Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnaire-based putative risk factor analysis.
    J Feline Med Surg, 9(4): 289-99. [Abstract] [Full-text]
71. Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.
    Muscle Nerve, 36(2): 264-6. [Abstract] [Full-text]
72. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
    Int J Pharm, 341(1): 230-7. [Abstract] [Full-text]
73. A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease.
    J Vasc Surg, 46(2): 271-279. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.